Table 4 Comparison of numbers of patients deriving clinical benefit vs progressive disease as assessed by RECIST vs CHOI

From: Patterns of response to anti-PD-1 treatment: an exploratory comparison of four radiological response criteria and associations with overall survival in metastatic melanoma patients

 

CHOI FU1

 

CHOI FU2

 

CHOI FU3

 

CHOI FU4

RECIST FU1

CR/PR/SD

PD

Total

RECIST FU2

CR/PR/SD

PD

Total

RECIST FU3

CR/PR/SD

PD

Total

RECIST FU4

CR/PR/SD

PD

Total

CR/PR/SD

21

2

23

CR/PR/SD

8

1

9

CR/PR/SD

11

0

11

CR/PR/SD

7

0

7

PD

3

11

14

PD

0

21

21

PD

2

3

5

PD

1

2

3

Total

24

13

37

Total

8

22

30

Total

13

3

16

Total

8

2

10

  1. Abbreviations: CR=complete response; PD=progressive disease; PR=partial response; SD=stable disease.